We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.71%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCUA
3001
DELISTED
Sculptor Acquisition Corp I
SCUA
$0 ﹤0.01%
+110,000
New +$1.12M
SCUA.WS
3002
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$0 ﹤0.01%
+55,000
New +$4.36K
BPACU
3003
DELISTED
Bullpen Parlay Acquisition Company Unit
BPACU
-110,000
Closed -$1.11M
VMGA
3004
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
$0 ﹤0.01%
+75,000
New +$755K
VMGAW
3005
DELISTED
VMG Consumer Acquisition Corp. Warrant
VMGAW
$0 ﹤0.01%
+37,500
New +$2.25K
GVCIW
3006
DELISTED
Green Visor Financial Technology Acquisition Corp. I Warrants
GVCIW
$0 ﹤0.01%
37,925
SVNAU
3007
DELISTED
7 Acquisition Corp Unit
SVNAU
-76,050
Closed -$772K
LMST
3008
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
-33,450
Closed -$657K
EUCR
3009
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
-22,427
Closed -$225K
SFT
3010
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
-7,730
Closed -$55K
RUBY
3011
DELISTED
Rubius Therapeutics, Inc
RUBY
-70,400
Closed -$31K
IVC
3012
DELISTED
Invacare Corporation
IVC
-90,300
Closed -$71K
IMGO
3013
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
-1,885,112
Closed -$28.4M
POSH
3014
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$0 ﹤0.01%
30,814
-369
-1% -$6.55K
SPNE
3015
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$0 ﹤0.01%
64,540
+359
+0.6% +$2.42K
CORZ
3016
DELISTED
Core Scientific, Inc. Common Stock
CORZ
-42,136
Closed -$55K
MNRL
3017
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
-8,293
Closed -$205K
HIL
3018
DELISTED
Hill International, Inc. Common Stock
HIL
-33,200
Closed -$111K
ABMD
3019
DELISTED
Abiomed Inc
ABMD
-130,875
Closed -$32.2M
CLVS
3020
DELISTED
Clovis Oncology, Inc.
CLVS
-85,900
Closed -$103K
VELOW
3021
DELISTED
Velocity Acquisition Corp. Warrant
VELOW
-11,329
Closed -$2K
VELO
3022
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
-33,986
Closed -$335K
BTRS
3023
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
-36,258
Closed -$336K
AFACW
3024
DELISTED
Arena Fortify Acquisition Corp. Warrant
AFACW
-37,500
Closed -$3K
AFAC
3025
DELISTED
Arena Fortify Acquisition Corp. Class A Common Stock
AFAC
-75,000
Closed -$756K

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.